Librería: BOOKWEST, Phoenix, AZ, Estados Unidos de America
Original o primera edición
EUR 26,79
Cantidad disponible: 1 disponibles
Añadir al carritoHardcover. Condición: New. 1st Edition. US SELLER SHIPS FAST FROM USA.
EUR 28,05
Cantidad disponible: 1 disponibles
Añadir al carritoCondición: Good. This is an ex-library book and may have the usual library/used-book markings inside.This book has hardback covers. In good all round condition. Please note the Image in this listing is a stock photo and may not match the covers of the actual item,650grams, ISBN:0306436671.
Idioma: Inglés
Publicado por Springer-Verlag New York Inc., New York, NY, 2012
ISBN 10: 1461367107 ISBN 13: 9781461367109
Librería: Grand Eagle Retail, Bensenville, IL, Estados Unidos de America
EUR 54,70
Cantidad disponible: 1 disponibles
Añadir al carritoPaperback. Condición: new. Paperback. More than 25 years have elapsed since the development of the seminal idea which led to the synthesis of dimethyl triazenes as antitumor agents. The original suggestion of Shealy et ale was to use 4-imidazone-carboxarnide as the carrier of a nitro- gen-containing cytotoxic function. 5-diazoimidazole-4-carbox- amide (diazo-IC) was synthesized and tested in mice as a potential inhibitor of de novo purine biosynthesis. Its lack of antitumor action was attributed to its polarity and to the resulting poor uptake of this hydrophilic chemical. Diazo-IC was then coupled with dimethylamine, yielding 5, (3,3-dimethyl- l-triazeno)imidazole-4-carboxamide) (DTIC) with the intention of obtaining a less polar and more lipophil~c prod rug which might release diazo-IC intracellularly. Preliminary tests showed that DTIC had good antiumor activity in experimental systems. Further tests demonstrated a broad spectrum of action against rodent tumors, and clinical trials indicated activity against human malignancies.Subsequent clinical use of DTIC has demonstrated its usefulness against malignant melanoma, for which it is currently the drug of choice, and its effective- ness in combination chemotherapy in the treatment of other human cancers. Because of its antitumor activity the mechan- ism of action of DTIC has been investigated in some detail. The original rationale for its development, that is, the hydrolysis in vivo to diazo-IC, has been shown not to be in- volved in th-e-mechansims of action. DTIC requires metabolic acti- vation before it exerts its biological effects. Chemical Biological and Clinical Aspects. Shipping may be from multiple locations in the US or from the UK, depending on stock availability.
Librería: FIRENZELIBRI SRL, Reggello, FI, Italia
EUR 15,00
Cantidad disponible: 1 disponibles
Añadir al carritoCondición: NUOVO. Bologna, Il Mulino cm.15x22, pp.248, brossura. Collana Psicologia in Pratica. La mindfulness è un costrutto psicologico e al tempo stesso una pratica meditativa che ha suscitato un vivo interesse in tutti gli ambiti del benessere e della salute mentale. Moltissime sono le iniziative che vanno sotto questa etichetta e che promettono benefici a tutti i livelli: dal sollievo allo stress alla soluzione di problemi psicopatologici importanti. Tutto questo ha creato molte aspettative e ha visto un fiorire di percorsi da un lato, e di interi approcci psicoterapeutici basati sulla mindfulness dall'altro, con particolare riferimento all'area cognitivo-comportamentale. Ma la mindfulness è davvero efficace? Va bene per tutti gli ambiti del disagio psicologico? In questo volume l'autore offre un'approfondita e articolata risposta su come, in quali casi e in quali condizioni gli approcci orientati alla mindfulness sono efficaci nella psicoterapia. Uno strumento per tutti i professionisti, psicologi e psicoterapeuti, per migliorare l'efficacia della terapia e sapere quando, ovvero con quali patologie, e come inserire interventi orientati alla mindfulness nella propria attività clinica.
Librería: Ria Christie Collections, Uxbridge, Reino Unido
EUR 60,51
Cantidad disponible: Más de 20 disponibles
Añadir al carritoCondición: New. In.
Librería: Chiron Media, Wallingford, Reino Unido
EUR 56,90
Cantidad disponible: 10 disponibles
Añadir al carritoPF. Condición: New.
Librería: Brook Bookstore, Milano, MI, Italia
EUR 17,77
Cantidad disponible: 4 disponibles
Añadir al carritoCondición: new.
Idioma: Italiano
ISBN 10: 8815290710 ISBN 13: 9788815290717
Librería: libreriauniversitaria.it, Occhiobello, RO, Italia
EUR 19,00
Cantidad disponible: 3 disponibles
Añadir al carritoCondición: NEW.
Librería: Ria Christie Collections, Uxbridge, Reino Unido
EUR 93,46
Cantidad disponible: Más de 20 disponibles
Añadir al carritoCondición: New. In.
EUR 15,00
Cantidad disponible: 1 disponibles
Añadir al carritopaperback. Condición: As New. Brossura editoriale di 120 pagine. Copia in condizioni pari al nuovo -- Dopo il Prozac, la cosiddetta "pillola della felicità", gli antidepressivi sono ormai giunti alla terza generazione. Ma nella gamma degli strumenti con cui si affronta oggi la malattia mentale, qual è la rilevanza degli psicofarmaci? Sono sempre e comunque efficaci? Il libro conduce il lettore lungo il percorso che dalla medicina antica porta alla nascita della medicina scientifica, illustrando il fenomeno della depressione in psichiatria, l'avvento della psicofarmacologia, con le sue luci ed ombre, sino alle più recenti esperienze di intervento psicoterapeutico in alternativa o in associazione con quello farmacoterapico. Book.
Librería: GreatBookPrices, Columbia, MD, Estados Unidos de America
EUR 108,17
Cantidad disponible: Más de 20 disponibles
Añadir al carritoCondición: New.
Librería: GreatBookPricesUK, Woodford Green, Reino Unido
EUR 93,45
Cantidad disponible: Más de 20 disponibles
Añadir al carritoCondición: New.
Librería: Ria Christie Collections, Uxbridge, Reino Unido
EUR 103,21
Cantidad disponible: Más de 20 disponibles
Añadir al carritoCondición: New. In English.
Idioma: Inglés
Publicado por Springer-Verlag New York Inc., New York, NY, 2012
ISBN 10: 1461367107 ISBN 13: 9781461367109
Librería: AussieBookSeller, Truganina, VIC, Australia
EUR 87,30
Cantidad disponible: 1 disponibles
Añadir al carritoPaperback. Condición: new. Paperback. More than 25 years have elapsed since the development of the seminal idea which led to the synthesis of dimethyl triazenes as antitumor agents. The original suggestion of Shealy et ale was to use 4-imidazone-carboxarnide as the carrier of a nitro- gen-containing cytotoxic function. 5-diazoimidazole-4-carbox- amide (diazo-IC) was synthesized and tested in mice as a potential inhibitor of de novo purine biosynthesis. Its lack of antitumor action was attributed to its polarity and to the resulting poor uptake of this hydrophilic chemical. Diazo-IC was then coupled with dimethylamine, yielding 5, (3,3-dimethyl- l-triazeno)imidazole-4-carboxamide) (DTIC) with the intention of obtaining a less polar and more lipophil~c prod rug which might release diazo-IC intracellularly. Preliminary tests showed that DTIC had good antiumor activity in experimental systems. Further tests demonstrated a broad spectrum of action against rodent tumors, and clinical trials indicated activity against human malignancies.Subsequent clinical use of DTIC has demonstrated its usefulness against malignant melanoma, for which it is currently the drug of choice, and its effective- ness in combination chemotherapy in the treatment of other human cancers. Because of its antitumor activity the mechan- ism of action of DTIC has been investigated in some detail. The original rationale for its development, that is, the hydrolysis in vivo to diazo-IC, has been shown not to be in- volved in th-e-mechansims of action. DTIC requires metabolic acti- vation before it exerts its biological effects. Chemical Biological and Clinical Aspects. Shipping may be from our Sydney, NSW warehouse or from our UK or US warehouse, depending on stock availability.
EUR 50,35
Cantidad disponible: 5 disponibles
Añadir al carritoTaschenbuch. Condición: Neu. Triazenes | Chemical, Biological, and Clinical Aspects | Tullio Giraldi (u. a.) | Taschenbuch | viii | Englisch | 2012 | Springer | EAN 9781461367109 | Verantwortliche Person für die EU: Springer Verlag GmbH, Tiergartenstr. 17, 69121 Heidelberg, juergen[dot]hartmann[at]springer[dot]com | Anbieter: preigu.
EUR 58,39
Cantidad disponible: 1 disponibles
Añadir al carritoTaschenbuch. Condición: Neu. Druck auf Anfrage Neuware - Printed after ordering - More than 25 years have elapsed since the development of the seminal idea which led to the synthesis of dimethyl triazenes as antitumor agents. The original suggestion of Shealy et ale was to use 4-imidazone-carboxarnide as the carrier of a nitro gen-containing cytotoxic function. 5-diazoimidazole-4-carbox amide (diazo-IC) was synthesized and tested in mice as a potential inhibitor of de novo purine biosynthesis. Its lack of antitumor action was attributed to its polarity and to the resulting poor uptake of this hydrophilic chemical. Diazo-IC was then coupled with dimethylamine, yielding 5, (3,3-dimethyl l-triazeno)imidazole-4-carboxamide) (DTIC) with the intention of obtaining a less polar and more lipophil~c prod rug which might release diazo-IC intracellularly. Preliminary tests showed that DTIC had good antiumor activity in experimental systems. Further tests demonstrated a broad spectrum of action against rodent tumors, and clinical trials indicated activity against human malignancies. Subsequent clinical use of DTIC has demonstrated its usefulness against malignant melanoma, for which it is currently the drug of choice, and its effective ness in combination chemotherapy in the treatment of other human cancers. Because of its antitumor activity the mechan ism of action of DTIC has been investigated in some detail. The original rationale for its development, that is, the hydrolysis in vivo to diazo-IC, has been shown not to be in volved in th-e-mechansims of action. DTIC requires metabolic acti vation before it exerts its biological effects.
Librería: Kennys Bookshop and Art Galleries Ltd., Galway, GY, Irlanda
EUR 115,98
Cantidad disponible: Más de 20 disponibles
Añadir al carritoCondición: New. 2017. Hardcover. . . . . .
Librería: Books Puddle, New York, NY, Estados Unidos de America
EUR 129,08
Cantidad disponible: 4 disponibles
Añadir al carritoCondición: New.
Librería: Ria Christie Collections, Uxbridge, Reino Unido
EUR 127,61
Cantidad disponible: Más de 20 disponibles
Añadir al carritoCondición: New. In.
Librería: Ria Christie Collections, Uxbridge, Reino Unido
EUR 127,61
Cantidad disponible: Más de 20 disponibles
Añadir al carritoCondición: New. In.
Librería: Revaluation Books, Exeter, Reino Unido
EUR 139,81
Cantidad disponible: 2 disponibles
Añadir al carritoHardcover. Condición: Brand New. 202 pages. 8.50x6.00x0.75 inches. In Stock.
Librería: Revaluation Books, Exeter, Reino Unido
EUR 140,36
Cantidad disponible: 2 disponibles
Añadir al carritoHardcover. Condición: Brand New. 236 pages. 9.61x6.69x0.56 inches. In Stock.
Librería: Kennys Bookstore, Olney, MD, Estados Unidos de America
EUR 146,93
Cantidad disponible: Más de 20 disponibles
Añadir al carritoCondición: New. 2017. Hardcover. . . . . . Books ship from the US and Ireland.
Librería: Kennys Bookshop and Art Galleries Ltd., Galway, GY, Irlanda
EUR 141,97
Cantidad disponible: 15 disponibles
Añadir al carritoCondición: New.
Librería: Kennys Bookshop and Art Galleries Ltd., Galway, GY, Irlanda
EUR 142,82
Cantidad disponible: 15 disponibles
Añadir al carritoCondición: New.
EUR 104,18
Cantidad disponible: Más de 20 disponibles
Añadir al carritoGebunden. Condición: New. KlappentextA class of antitumor agents is discussed in 16 papers, which include explorations of the synthesis, chemical properties, biotransformation, and pharmacokinetics in animals and humans, and studies of analogous agents and substa.
Librería: Books Puddle, New York, NY, Estados Unidos de America
EUR 155,77
Cantidad disponible: 4 disponibles
Añadir al carritoCondición: New. pp. 238.
Librería: Books Puddle, New York, NY, Estados Unidos de America
EUR 156,15
Cantidad disponible: 4 disponibles
Añadir al carritoCondición: New. pp. XV, 238 1 illus. 1st ed. 2019 edition NO-PA16APR2015-KAP.
Librería: preigu, Osnabrück, Alemania
EUR 86,20
Cantidad disponible: 5 disponibles
Añadir al carritoTaschenbuch. Condición: Neu. Unhappiness, Sadness and 'Depression' | Antidepressants and the Mental Disorder Epidemic | Tullio Giraldi | Taschenbuch | xiv | Englisch | 2018 | Springer | EAN 9783319862187 | Verantwortliche Person für die EU: Springer Verlag GmbH, Tiergartenstr. 17, 69121 Heidelberg, juergen[dot]hartmann[at]springer[dot]com | Anbieter: preigu.
Idioma: Inglés
Publicado por Springer International Publishing, Springer International Publishing, 2018
ISBN 10: 3319862189 ISBN 13: 9783319862187
Librería: AHA-BUCH GmbH, Einbeck, Alemania
EUR 96,29
Cantidad disponible: 1 disponibles
Añadir al carritoTaschenbuch. Condición: Neu. Druck auf Anfrage Neuware - Printed after ordering - This book examines existing treatments, legislation and research methodology of depression and exposes their limitations, championing psycho-social support as an alternative. Depression, affecting 350 million people according to the World Health Organisation, is almost invariably diagnosed by the criteria of the American Psychiatric Association - a definition which encompasses those with normal emotional responses to stressful life events. Tullio Giraldi discusses recent developments in popular and academic dialogue related to the use of antidepressants and recent increases in depression diagnosis and laments the rise in prescribing antidepressants despite their links to suicide and unfulfilled promises of efficacy and safety. He argues that psychotherapy is a cost effective treatment devoid of drugs' adverse effects. This work presents psycho-social support as an alternative to antidepressants, particularly for less severe cases, and as a more effective strategy for coping with the emotional challenges of today's global reality. Patients, students of medicine and psychology, and professionals of mental health will find this work valuable.